Baracaldo Rafael M, Bao Dashi, Iampornpipopchai Pichet, Fogel Joshua, Rubinstein Sofia
Division of Nephrology and Hypertension, Nassau University Medical Center, East Meadow, NY, USA.
Department of Finance and Business Management, Brooklyn College, Brooklyn, NY, USA.
Hemodial Int. 2015 Oct;19(4):583-92. doi: 10.1111/hdi.12298. Epub 2015 Mar 31.
Osteitis fibrosa cystica (OFC) is the most frequent type of osseous change in renal osteodystrophy affecting the majority of dialysis patients. Brown tumors are a severe form of OFC. The involvement of the craniofacial skeleton causing facial disfigurement in patients on dialysis appears to be limited to case reports. After searching PubMed, we performed a systematic review of 127 cases with a severe form of OFC resulting in a facial disfigurement to understand possible determinants for this condition. We found that since the first published case in 1974, and after a peak in 1996, there appears to be an increase in published reported cases. Only 27.6% of these cases were published in nephrology journals. The most common region for reported cases was North America. Mean age of these patients was 31.2 years with a mean dialysis duration of 7 years. Almost 67% were women, and almost all were on hemodialysis. The disease tended to most commonly localize to the maxilla (73.2%) and mandible (57.5%). As part of the treatment, 59% of patients had a parathyroidectomy. More than one-third (35.4%) had symptomatic improvement at follow-up. Mean follow-up was 1.6 years. Clinicians should be aware of this clinical presentation of a severe form of OFC and/or brown tumors. Timely diagnosis and intervention may help to prevent or decrease destructive bone changes and reduce negative psychological consequences of facial disfigurement.
纤维囊性骨炎(OFC)是肾性骨营养不良中最常见的骨改变类型,影响大多数透析患者。棕色瘤是OFC的一种严重形式。透析患者中颅面骨骼受累导致面部畸形的情况似乎仅限于病例报告。在检索了PubMed之后,我们对127例导致面部畸形的严重OFC病例进行了系统综述,以了解这种情况的可能决定因素。我们发现,自1974年首次发表病例以来,在1996年达到峰值后,已发表的报告病例似乎有所增加。这些病例中只有27.6%发表在肾脏病学杂志上。报告病例最常见的地区是北美。这些患者的平均年龄为31.2岁,平均透析时间为7年。几乎67%为女性,几乎所有患者都接受血液透析。该病最常累及上颌骨(73.2%)和下颌骨(57.5%)。作为治疗的一部分,59%的患者进行了甲状旁腺切除术。超过三分之一(35.4%)的患者在随访时有症状改善。平均随访时间为1.6年。临床医生应了解这种严重形式的OFC和/或棕色瘤的临床表现。及时诊断和干预可能有助于预防或减少破坏性骨改变,并减少面部畸形的负面心理影响。